GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (STU:N460) » Definitions » Total Receivables

Medicus Pharma (STU:N460) Total Receivables : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medicus Pharma Total Receivables?

Medicus Pharma's Total Receivables for the quarter that ended in Dec. 2024 was €0.00 Mil.


Medicus Pharma Total Receivables Historical Data

The historical data trend for Medicus Pharma's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Total Receivables Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Receivables
- - - -

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medicus Pharma Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Medicus Pharma Total Receivables Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicus Pharma Business Description

Traded in Other Exchanges
Address
100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.

Medicus Pharma Headlines

No Headlines